PMID: 9544424Apr 17, 1998Paper

Role of nitric oxide in angiogenesis and microcirculation in tumors

Cancer Metastasis Reviews
Dai Fukumura, R K Jain

Abstract

Nitric oxide (NO) is a free radical molecule with high reactivity, a short half life and a variety of physiological activities. The role of NO in tumor microcirculation, based on the data collected to date, can be summarized as follows: 1) NO may partially mediate tumor angiogenesis; 2) endogenous NO derived from tumor vascular endothelium and/or tumor cells increases and/or maintains tumor blood flow via dilatation of arteriolar vessels, decreases leukocyte-endothelial interaction, and increases vascular permeability; 3) exogenous NO can increase tumor blood flow via vessel dilatation, and reduce vessel tone; and 4) NO production rates and vascular response to NO are heterogeneous and tumor-dependent. Modulation of NO level in tumor vessels can alter tumor hemodynamics and thus augment oxygen, drug, gene vector and effector cell delivery to solid tumors.

Citations

Oct 16, 1999·Anesthesiology·W SteudelW M Zapol
Nov 18, 2000·Proceedings of the Society for Experimental Biology and Medicine·T Yamamoto, R J Bing
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·D FukumuraR K Jain
Jun 19, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·P G PhillipsW L Milonovich
Nov 16, 2002·Archives of Pharmacal Research·In Duk JungHoi Young Lee
Apr 10, 2004·Cancer Science·Satoshi IgawaHirosuke Kobayashi
Jul 5, 2005·Expert Opinion on Investigational Drugs·R M Phillips
Oct 27, 2005·Journal of Biochemistry and Molecular Biology·Key-Sun Kim
Apr 15, 2006·The Journal of Nutrition·Steven J T Jackson, Richard C Venema
Jul 29, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Daniela MassiClelia Miracco
Apr 25, 2008·Critical Care Medicine·Alessandra BittoDomenica Altavilla
Sep 9, 2010·Cell Communication and Signaling : CCS·Lido Calorini, Francesca Bianchini
Feb 2, 2011·Chemical Communications : Chem Comm·Raphaël TrouillonDanny O'Hare
Jun 7, 2013·Scanning·Yimei HuangShusen Xie
Feb 18, 2015·Journal of Cancer Research and Clinical Oncology·Martin Alejandro KrasnapolskiAna María Eiján
Nov 10, 2001·Annual Review of Biomedical Engineering·R K Jain
Jun 11, 1999·International Journal of Cancer. Journal International Du Cancer·A OrucevicP K Lala
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Efstathia GiannopoulouEvangelia Papadimitriou
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Kerstin DallmannReinhard Walther
Apr 8, 2003·World Journal of Gastroenterology : WJG·Hong-Xia LiShui-Xiang He
Mar 9, 2005·Cancer·Mohan AdithiSubramanian Krishnakumar
Jun 14, 2005·The Journal of Clinical Investigation·Satoshi KashiwagiDai Fukumura
Sep 20, 2006·Expert Opinion on Therapeutic Targets·George Van BurenLee M Ellis
Apr 16, 2008·BJU International·Rituraj KonwarHemant Kumar Bid
Jan 16, 2010·International Journal of Immunopathology and Pharmacology·G GuidaC Bucca
Apr 3, 2010·Pharmacological Reports : PR·Nian-Hong ChenJian-Jiang Zhong
Jan 26, 2010·Immunopharmacology and Immunotoxicology·Vinod Prabhu, C Guruvayoorappan
Nov 10, 2010·Immunopharmacology and Immunotoxicology·T P Hamsa, Girija Kuttan
Mar 20, 2018·Oncology Letters·Fernando Francisco Borges ResendeRicardo Titze-de-Almeida
Jun 6, 2000·British Journal of Cancer·M KorbelikD J Chaplin
May 19, 2000·The Journal of Biological Chemistry·M MariottiJ A Maier
Mar 19, 2002·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Yuk-Kwan ChenLi-Min Lin
Jun 26, 2001·Diabetes/metabolism Research and Reviews·N KasaiT Suda
Feb 15, 2001·Veterinary Surgery : VS·L M Howe, H W Boothe
Jan 23, 2003·Microscopy Research and Technique·Michael J B Kutryk, Duncan J Stewart
Feb 21, 2004·The Japanese Journal of Physiology·Chika MiyoshiNorio Ohshima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.